The Importance of Female Inclusion in Clinical Trials

Towards a More Inclusive Future

Rinki Minakshi (Autor)

Buch | Hardcover

185 Seiten

2024 | Unabridged edition
Cambridge Scholars Publishing (Verlag)
978-1-0364-0428-4 (ISBN)

Artikel merken

The torments of the COVID-19 pandemic overwhelmed our medical system and steered the way to the unprecedented introduction of the COVID-19 vaccine, which saved many lives. But the vaccine also gave rise to health issues in the female population. The clinical trials deliberately marginalized females, giving a biased result. This book is needed at this point of time because we can't ignore female health anymore. We are in need of more extensive studies on gender-based diversification of the microbiome and its mechanisms. The book argues that the dosage and timing of vaccination during the menstrual cycle must be an important factor. The emphasis should be on overcoming the notion of 'bikini medicine' and on providing treatment to females as individuals who have standards that can't be equated with the male system. The book will be of interest to researchers keen on exploring issues related to female physiology post drug treatment/vaccination.

Dr Rinki Minakshi is a virologist and molecular biologist with wide research interests. She has extensive experience in teaching undergraduate as well as post graduate students. Her portfolio of publications in highly reputed journals focusses upon research areas involving SARS-CoV, SARS-CoV-2 and breast cancer.

Erscheinungsdatum	22.08.2024
Verlagsort	Newcastle upon Tyne
Sprache	englisch
Maße	148 x 212 mm
Themenwelt	Medizin / Pharmazie ► Studium ► 1. Studienabschnitt (Vorklinik)
Themenwelt	Sozialwissenschaften ► Soziologie ► Gender Studies
ISBN-10	1-0364-0428-5 / 1036404285
ISBN-13	978-1-0364-0428-4 / 9781036404284
Zustand	Neuware